Literature DB >> 17278946

New onset systemic lupus erythematosus in a transgender man: possible role of feminizing sex hormones.

Alberto S Santos-Ocampo1.   

Abstract

Systemic lupus erythematosus (SLE) is rare in men, and significantly more common in women. Sex hormone influences are believed to a play a role in these gender differences. We present the unusual case of a transgender man who had been taking feminizing sex hormones, who later developed new onset SLE with cardiorespiratory and renal involvement. While not definitive, this case raises intriguing possibilities on the relationship between the use of feminizing sex hormones and the development of SLE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17278946     DOI: 10.1097/01.rhu.0000256169.05087.ad

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  6 in total

Review 1.  Review: Male systemic lupus erythematosus: a review of sex disparities in this disease.

Authors:  L-J Lu; D J Wallace; M L Ishimori; R H Scofield; M H Weisman
Journal:  Lupus       Date:  2009-11-27       Impact factor: 2.911

2.  Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals.

Authors:  Jamie D Weinand; Joshua D Safer
Journal:  J Clin Transl Endocrinol       Date:  2015-06

Review 3.  Gender-Diverse Inclusion in Immunological Research: Benefits to Science and Health.

Authors:  Hannah Peckham; Kate Webb; Elizabeth C Rosser; Gary Butler; Coziana Ciurtin
Journal:  Front Med (Lausanne)       Date:  2022-07-14

Review 4.  Why are women predisposed to autoimmune rheumatic diseases?

Authors:  Jacqueline E Oliver; Alan J Silman
Journal:  Arthritis Res Ther       Date:  2009-10-26       Impact factor: 5.156

Review 5.  Androgen-Mediated Anti-inflammatory Cellular Processes as Therapeutic Targets in Lupus.

Authors:  Jessica M Jones; Trine N Jørgensen
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

6.  Estrogen Reverses HDAC Inhibitor-Mediated Repression of Aicda and Class-Switching in Antibody and Autoantibody Responses by Downregulation of miR-26a.

Authors:  Paolo Casali; Tian Shen; Yijiang Xu; Zhifang Qiu; Daniel P Chupp; John Im; Zhenming Xu; Hong Zan
Journal:  Front Immunol       Date:  2020-03-24       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.